Science Explorer Back to mapMap
Discussion

Rubicon Biotechnology (United States)

Research works
20
▲ 53% vs 2018-21
Citations
307
15.4 per fractional work
Top-10% rate
3.9%
all institutions 10.0%
Open access
52%
world 40%
International
17%
world 18%
Rubicon Biotechnology (United States)

Not ranked overall: Rubicon Biotechnology (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Rubicon Biotechnology (United States) work in?

In all years, 47% of research at Rubicon Biotechnology (United States) is in Physical Sciences, 24% in Health Sciences. Its largest fields are Engineering (29%), Medicine (20%), Biochemistry, Genetics and Molecular Biology (13%).

Physical Sciences: 9 fractional works · 46.6% of its workEngineering: 6 fractional works · 28.6% of its workControl and Systems Engineering: 2 fractional works · 8.8% of its workMedia Technology: 1 fractional works · 5.9% of its workComputational Mechanics: 1 fractional works · 5.0% of its workElectrical and Electronic Engineering: 1 fractional works · 3.4% of its workMechanical Engineering: 0 fractional works · 2.1% of its workAutomotive Engineering: 0 fractional works · 1.9% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 1.7% of its workComputer Science: 2 fractional works · 10.1% of its workComputer Networks and Communications: 2 fractional works · 7.5% of its workInformation Systems: 0 fractional works · 1.7% of its workArtificial Intelligence: 0 fractional works · 0.9% of its workMaterials Science: 1 fractional works · 5.9% of its workMaterials Chemistry: 1 fractional works · 3.4% of its workPolymers and Plastics: 0 fractional works · 2.5% of its workEnergy: 0 fractional works · 1.7% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 1.7% of its workEarth and Planetary Sciences: 0 fractional works · 0.2% of its workEnvironmental Science: 0 fractional works · 0.2% of its workHealth Sciences: 5 fractional works · 24.4% of its workMedicine: 4 fractional works · 20.3% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 4.7% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 3.5% of its workNephrology: 1 fractional works · 3.4% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 1.7% of its workPhysiology: 0 fractional works · 1.3% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.9% of its workEmergency Medicine: 0 fractional works · 0.9% of its workEpidemiology: 0 fractional works · 0.8% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.7% of its workPathology and Forensic Medicine: 0 fractional works · 0.7% of its workSurgery: 0 fractional works · 0.6% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.4% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.4% of its workInfectious Diseases: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workHealth Professions: 1 fractional works · 4.1% of its workGeneral Health Professions: 1 fractional works · 2.6% of its workEmergency Medical Services: 0 fractional works · 1.1% of its workPharmacy: 0 fractional works · 0.4% of its workLife Sciences: 4 fractional works · 18.0% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 13.2% of its workMolecular Biology: 2 fractional works · 10.6% of its workCancer Research: 0 fractional works · 1.9% of its workBiotechnology: 0 fractional works · 0.4% of its workBiophysics: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 0 fractional works · 2.5% of its workPlant Science: 0 fractional works · 2.5% of its workImmunology and Microbiology: 0 fractional works · 2.0% of its workImmunology: 0 fractional works · 2.0% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.4% of its workPharmaceutical Science: 0 fractional works · 0.4% of its workSocial Sciences: 2 fractional works · 11.0% of its workSocial Sciences: 2 fractional works · 7.5% of its workSociology and Political Science: 1 fractional works · 2.8% of its workGeography, Planning and Development: 0 fractional works · 1.7% of its workPolitical Science and International Relations: 0 fractional works · 1.7% of its workHealth: 0 fractional works · 0.9% of its workEducation: 0 fractional works · 0.6% of its workBusiness, Management and Accounting: 0 fractional works · 2.2% of its workOrganizational Behavior and Human Resource Management: 0 fractional works · 1.4% of its workStrategy and Management: 0 fractional works · 0.9% of its workDecision Sciences: 0 fractional works · 0.9% of its workInformation Systems and Management: 0 fractional works · 0.9% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.4% of its workEconomics and Econometrics: 0 fractional works · 0.4% of its workALL ITS WORKRubiconBiotechnology…20fractional works, all years
Life Sciences18%Physical Sciences47%Health Sciences24%Social Sciences11%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Engineering628.6%
    2. Computer Science210.1%
    3. Materials Science15.9%
    4. Energy01.7%
    5. Earth and Planetary Sciences00.2%
    6. Environmental Science00.2%
    1. Medicine420.3%
    2. Health Professions14.1%
    1. Biochemistry, Genetics and Molecular Biology313.2%
    2. Agricultural and Biological Sciences02.5%
    3. Immunology and Microbiology02.0%
    4. Pharmacology, Toxicology and Pharmaceutics00.4%
    1. Social Sciences27.5%
    2. Business, Management and Accounting02.2%
    3. Decision Sciences00.9%
    4. Economics, Econometrics and Finance00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.24× its world share, 0 worksBiochemistry, Geneti…Pharmacology, Toxicology and Pharmaceutics: 3.06× its world share, 0 worksPharmacology, Toxico…Energy: 4.69× its world share, 0 worksEnergyEngineering: 3.09× its world share, 4 worksEngineeringMaterials Science: 1.24× its world share, 0 worksMaterials ScienceHealth Professions: 1.36× its world share, 0 worksHealth ProfessionsMedicine: 1.36× its world share, 2 worksMedicineSocial Sciences: 1.02× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Energy, 4.7×. Every wedge is a field page.

All 8 fields, with their numbers
  1. Energy4.69×0 works
  2. Engineering3.09×4 works
  3. Pharmacology, Toxicology and Pharmaceutics3.06×0 works
  4. Health Professions1.36×0 works
  5. Medicine1.36×2 works
  6. Materials Science1.24×0 works
  7. Social Sciences1.02×1 works
  8. Biochemistry, Genetics and Molecular Biology0.24×0 works

What are the most cited papers from Rubicon Biotechnology (United States)?

The most cited paper from Rubicon Biotechnology (United States) is "Browsing as the killer app: Explaining the rapid success of Apple's iPhone" (Joel West, Michael Mace, 2010), with 305 citations. Next come "A Mobile Phone-Based Health Coaching Intervention for Weight Loss and Blood Pressure Reduction in a National Payer Population: A Retrospective Study" (93) and "Catalytic oxidative dehydrogenation of propane over Mg–V/Mo oxides" (75).

Most cited papers
#PaperReleasedCitations
1 Browsing as the killer app: Explaining the rapid success of Apple's iPhone Joel West, Michael Mace · Telecommunications Policy 9 Feb 2010 305
2 A Mobile Phone-Based Health Coaching Intervention for Weight Loss and Blood Pressure Reduction in a National Payer Population: A Retrospective Study Alice Mao, Connie E-Jean Chen, Candy Magaña et al. · JMIR mhealth and uhealth Open access 8 Jun 2017 93
3 Catalytic oxidative dehydrogenation of propane over Mg–V/Mo oxides Jason D. Pless, Billy B. Bardin, Hacksung Kim et al. · Journal of Catalysis 20 Mar 2004 75
4 Phosgene: toxicology, animal models, and medical countermeasures Stephen T. Hobson, Richard A. Richieri, Missag Hagop Parseghian · Toxicology Mechanisms and Methods Open access 18 Feb 2021 49
5 Cardioprotective Effects of HSP72 Administration on Ischemia-Reperfusion Injury Takashi Tanimoto, Missag Hagop Parseghian, Takehiro Nakahara et al. · Journal of the American College of Cardiology Open access Sep 2017 46
All 34 most cited papers, with filters and sorting

Which research topics does Rubicon Biotechnology (United States) publish most on?

By volume in 2022-now: Astronomical Observations and Instrumentation, Real-time simulation and control systems, Advanced Data Processing Techniques and Electric Power Systems and Control.

  1. 1 Astronomical Observations and Instrumentation Computational Mechanics 1 works
  2. 2 Real-time simulation and control systems Control and Systems Engineering 1 works
  3. 3 Advanced Data Processing Techniques Control and Systems Engineering 0 works
  4. 4 Electric Power Systems and Control Electrical and Electronic Engineering 0 works
  5. 5 Chronic Kidney Disease and Diabetes Nephrology 0 works
  6. 6 Hungarian Social, Economic and Educational Studies Geography, Planning and Development 0 works
  7. 7 Central European and Russian historical studies Political Science and International Relations 0 works
  8. 8 Diverse Industrial Engineering Technologies Industrial and Manufacturing Engineering 0 works
  9. 9 Advanced Materials and Semiconductor Technologies Materials Chemistry 0 works
  10. 10 Dialysis and Renal Disease Management Nephrology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.7%not open48.3%

World: 40% of research is openly available.

with international co-authors16.6%domestic only83.4%

World: 18% is written across borders.

How has Rubicon Biotechnology (United States)'s research output changed?

Output in 2022-2025 was 53% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Rubicon Biotechnology (United States) as a percentage of every work published that year, 0.000045% in 2024.

still counting0.00010%0.00020%0.00030%Rubicon Biotechnology (United States)0.0000090% in 20251990200020102020

Fractional works of Rubicon Biotechnology (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Lake Forest

All research institutions in Lake Forest

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Rubicon Biotechnology (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.